ACADIA Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

ACADIA Pharmaceuticals Stock Summary

ACADIA Pharmaceuticals competes with Madrigal Pharmaceuticals, Viking Therapeutics, Sarepta Therapeutics, Hepion Pharmaceuticals, and PTC Therapeutics. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. Acadia Pharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 540 people.

ACADIA Pharmaceuticals Key Financial Ratios

ACADIA Pharmaceuticals Key Balance Sheet Accounts

ACADIA Pharmaceuticals Key Income Statement Accounts

ACADIA Pharmaceuticals Key Cash Accounts

ACADIA Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ACADIA Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare ACADIA Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ACADIA Pharmaceuticals competition to find correlations between indicators driving ACADIA Pharmaceuticals's intrinsic value. More Info.ACADIA Pharmaceuticals is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about  0.14  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ACADIA Pharmaceuticals is roughly  7.15 . At present, ACADIA Pharmaceuticals' Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value ACADIA Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

ACADIA Pharmaceuticals Systematic Risk

Today, most investors in ACADIA Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ACADIA Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ACADIA Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of ACADIA Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ACADIA Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of ACADIA Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing ACADIA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ACADIA Pharmaceuticals's daily price indicators and compare them against related drivers.

When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.